oraCMU and oraCMS1 -Therapeutic Efficacy of Asthma Improvement

 

 

oraCMU, oraCMS1 Therapeutic Efficacy of Asthma Improvement

 

 

The Orapharm R&D team announced that a paper on the effect of improving asthma has been published in the international academic journal "Medicina (SCIE-class) on the 29th of September. 

 

The research paper "The Therapy Effectiveness of Weissella Cibaria CMU and CMS1 on Allergic Infection Exacerbated by Diesel Exhaust Particulate Matter in a Murine Asthma Model" was jointly conducted by Orapharm Research and Development Team and Chungbuk National University Veterinary College.

 

The study proved the efficacy of asthma-related treatments of Weissella cibaria CMU and CMS1 through in vivo testing , and used diesel exhaust particulate matter (DEPM) which is an asthma-related pollutant, and Synatura as an active control.

 

Dr. Mi-sun Kang, the author of the paper, said, "It is a valuable result of confirming the excellence of the Weissella cibaria CMU and CMS1 strain and obtaining oral probiotics as effective in improving asthma."

 

 

To read the article in Korean, click here